SCHRODER INVESTMENT MANAGEMENT GROUP

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1086619 London, X0

Position in RARE

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$3,752,081

-$287,524 QoQ

Shares Held

179,097

+2.0% QoQ

Ownership

0.182%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $603,082,920 across 77 Biotechnology names. RARE ranks #41 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	163,898	$73,187,011
2	TECH	BIO-TECHNE Corp	1,197,214	$62,566,403
3	EXEL	Exelixis, Inc.	525,533	$22,540,109
4	ALNY	Alnylam Pharmaceuticals, Inc.	66,662	$22,056,454
5	SLNO	Soleno Therapeutics Inc	648,827	$21,722,727
6	MDGL	Madrigal Pharmaceuticals, Inc.	39,852	$20,861,326
7	INSM	INSMED Inc	119,958	$19,615,531
8	VERA	Vera Therapeutics, Inc.	484,381	$19,486,647

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,752,081	179,097	+2.0%	Shares	Sole	2026-05-14
2025-12-31	$4,039,605	175,635	+16.6%	Shares	Sole	2026-02-13
2025-09-30	$4,529,175	150,571	-55.2%	Shares	Sole	2025-11-13
2025-06-30	$12,223,250	336,173	+27.2%	Shares	Sole	2025-08-13
2025-03-31	$9,569,759	264,285	-29.7%	Shares	Sole	2025-05-13
2024-12-31	$15,825,093	376,161	+105.7%	Shares	Sole	2025-02-12
2024-09-30	$10,158,150	182,865	-48.8%	Shares	Sole	2024-11-13
2024-06-30	$14,690,701	357,438	+40.1%	Shares	Sole	2024-08-12
2024-03-31	$11,909,591	255,078	+2.0%	Shares	Sole	2024-05-14
2023-12-31	$11,957,486	250,052	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.